Humana (FRA:HUM) Cyclically Adjusted Revenue per Share: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HUM Humana Inc FRA:HUM
83 GF Score
Price €334.00
GF Value €320.66
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Humana Cyclically Adjusted Revenue per Share?

Humana FRA:HUM +0.60% 83 Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus rates FRA:HUM with a GF Score™ of 83/100 and a GF Value™ of €320.66 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Humana's adjusted revenue per share for the three months ended in Jun. 2026 was €290.156. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Humana's average Cyclically Adjusted Revenue Growth Rate was 13.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Humana was 15.50% per year. The lowest was 5.90% per year. And the median was 12.20% per year.

As of today (2026-09-20), Humana's current stock price is €334.00. Humana's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was . Humana's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Humana was 1.19. The lowest was 0.22. And the median was 0.89.


Humana  (FRA:HUM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Humana was 1.19. The lowest was 0.22. And the median was 0.89.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Humana Cyclically Adjusted Revenue per Share Related Terms


Humana Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Humana's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humana Cyclically Adjusted Revenue per Share Chart

Humana Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Humana Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FRA:HUM vs CNC, CI, MOH: Cyclically Adjusted Revenue per Share Comparison

For the Healthcare Plans subindustry, Humana's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humana Cyclically Adjusted PS Ratio vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Humana's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Humana's Cyclically Adjusted PS Ratio falls into.


FRA:HUM
83GF Score
Humana Inc FRA:HUM
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humana Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Humana's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=290.156/333.9520*333.9520
=290.156

Current CPI (Jun. 2026) = 333.9520.

Humana Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 81.312 241.428 112.474
201612 79.864 241.432 110.469
201703 86.734 243.801 118.806
201706 84.448 244.955 115.130
201709 77.852 246.819 105.336
201712 78.622 246.524 106.505
201803 83.688 249.554 111.991
201806 86.363 251.989 114.454
201809 88.072 252.439 116.511
201812 90.282 251.233 120.008
201903 104.392 254.202 137.143
201906 106.701 256.143 139.114
201909 109.057 256.759 141.844
201912 110.494 256.974 143.593
202003 129.413 258.115 167.436
202006 130.269 257.797 168.751
202009 129.029 260.280 165.551
202012 121.043 260.474 155.188
202103 132.451 264.877 166.992
202106 132.454 271.696 162.804
202109 142.784 274.310 173.829
202112 142.791 278.802 171.037
202203 167.617 287.504 194.697
202206 174.711 296.311 196.905
202209 177.724 296.808 199.965
202212 175.192 296.797 197.124
202303 198.496 301.836 219.616
202306 196.433 305.109 215.002
202309 195.899 307.789 212.551
202312 200.980 306.746 218.805
202403 224.976 312.332 240.549
202406 227.394 314.175 241.708
202409 221.589 315.301 234.697
202412 227.359 315.605 240.576
202503 252.485 319.799 263.659
202506 236.653 322.561 245.010
202509 231.380 324.800 237.900
202512 232.140 324.054 239.231
202603 280.885 330.213 284.065
202606 290.156 333.952 290.156

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of € mean?
Humana (FRA:HUM) has a Cyclically Adjusted Revenue per Share of € as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Humana and its competitors.
Is Humana's Cyclically Adjusted Revenue per Share too high?
Humana's current Cyclically Adjusted Revenue per Share is €. Overall, Humana has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Humana's Cyclically Adjusted Revenue per Share compare to CNC and CI?
Humana's Cyclically Adjusted Revenue per Share of € can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Plans company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Plans industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Humana and its competitors. Humana's current Cyclically Adjusted Revenue per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana stock overvalued right now?
Based on GuruFocus' analysis, Humana (FRA:HUM) is currently considered Fairly Valued. The stock's GF Value™ is €320.66, compared to a current price of €334.00 — trading 4.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €. Humana's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Humana (FRA:HUM), the current Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humana (FRA:HUM) Overvalued in 2026?

Based on GuruFocus' analysis, Humana stock appears to be overvalued. The current stock price of €334.00 is trading 4.2% above its estimated GF Value™ of €320.66. GuruFocus considers Humana to be Fairly Valued.

Key valuation signals for FRA:HUM:

  • Cyclically Adjusted Revenue per Share:
  • GF Value™: €320.66 vs. price of €334.00 (4.2% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the FRA:HUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Humana Business Description

Address 101 East Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
83GF Score

Get the complete analysis for FRA:HUM

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€334.00
Price
€320.66
GF Value